Belief BioMed and Takeda China jointly announced BBM-H901 (Dalnacogene Ponparvovec Injection), China’s first hemophilia B gene therapy, was officially approved
SHANGHAI, April 10, 2025 /PRNewswire/ -- Belief BioMed ("BBM") and Takeda China today jointly announced that BBM-H901 (generic name: Dalnacogene Ponparvovec Injection), has been officially approved by the National Medical Products Administration (NMPA) for the treatment of adult patients with moderate to severe hemophilia B (congenital coagulation factor IX deficiency). As the first approved hemophilia B gene therapy in China1, BBM-H901...
Medtec Southeast Asia 2025 – The Southeast Asia’s Premier Medical Device Design & Manufacturing Exhibition Debuts in Malaysia
KUALA LUMPUR, Malaysia, April 10, 2025 /PRNewswire/ -- Informa Markets announces the launch of Medtec Southeast Asia 2025, the premier medical device design and manufacturing exhibition in Southeast Asia, making its debut in Malaysia. The inaugural Medtec Southeast Asia 2025 exhibition will take place from July 16 to 18, 2025, at the Malaysia International Trade & Exhibition Centre (MITEC)...
Angel Yeast Delivers Critical Aid to Myanmar Earthquake Victims, Reinforcing Commitment to Global Humanitarian Efforts
YANGON, Myanmar, April 10, 2025 /PRNewswire/ -- In rapid response to Myanmar's catastrophic 7.9-magnitude earthquake, Angel Yeast Co., Ltd. has mobilized emergency relief supplies through the Myanmar Chinese Chamber of Commerce. This decisive action places Angel Yeast at the forefront of first responders, providing essential aid directly to the communities struck by this...
Fangzhou Showcases AI Governance Breakthroughs at Guangzhou Closed-Door Summit on Vertical-Specific AI Models
GUANGZHOU, China, April 10, 2025 /PRNewswire/ -- Fangzhou Inc. ("Fangzhou" or the "Company") (06086.HK), a leading Internet healthcare solution provider, emerged as the sole digital health innovator invited to the Modern Industrial System Development Summit hosted by the Guangzhou Industrial Development Research Institute on April 1, 2025. At the closed-door forum, executives from...
Amcor builds cutting-edge coating facility, enhancing healthcare packaging access in Asia Pacific
New facility enhances supply chain security, reduces lead times and supports customers' growth First in Asia equipped with advanced air knife coating technology First in Asia to produce both top and bottom substrates for medical device packaging ZURICH, April 10, 2025 /PRNewswire/ -- Amcor (NYSE: AMCR, ASX: AMC), a global leader in developing and producing responsible packaging solutions, today...
Harbour BioMed Appoints Youchen Chen as Chief Financial Officer
CAMBRIDGE, Mass., ROTTERDAM, Netherlands and SHANGHAI , April 10, 2025 /PRNewswire/ -- Harbour BioMed (HKEX: 02142), a global biopharmaceutical company committed to the discovery and development of novel antibody therapeutics focusing on immunology and oncology, today announced the appointment of Youchen (YC) Chen as Chief Financial Officer. YC will be based in Shanghai and Hong...
VCI BIOFUELS GROUP SIGNS DEFINITIVE MERGER AGREEMENT WITH INTERNATIONAL MEDIA ACQUISITION CORP. TO PUBLICLY LIST ON THE NASDAQ
NEW YORK, April 10, 2025 /PRNewswire/ -- The Vietnamese ethanol production company, Vietnam Biofuels Development Joint Stock Company and its affiliates (together, "Vietnam Biofuels" or "VNB"), VCI Holdings Limited ("VCI" and together with VNB, the "VCI Biofuels Group") and International Media Acquisition Corp. (OTC: IMAQ) ("IMAQ") are pleased to announce today that they have entered into a definitive...
APHRANEL Global Launch Meeting, in Shanghai China
APHRANEL Global Launch Meeting: Code Breaker, World Maker SHANGHAI, April 9, 2025 /PRNewswire/ -- On May 8, 2025——The APHRANEL Global Launch Meeting will be grandly held at the Shanghai World Reception Hall, overlooking the Bund! We warmly welcome esteemed experts, partners, investors, and consumers worldwide to join this milestone event, celebrating "APHRANEL: Code Breaker, World Maker". ...
Lunit Study in Radiology Highlights Trust Gap Between Radiologists and AI in Breast Cancer Screening
Despite strong performance from AI, fewer recalls from AI-flagged cases point to challenges in human-AI collaboration SEOUL, South Korea, April 9, 2025 /PRNewswire/ -- Lunit (KRX:328130.KQ), a leading provider of AI-powered solutions for cancer diagnostics and therapeutics, today announced the publication of a new study in Radiology (RSNA's flagship journal), highlighting how...
Seegene Announces Development of CURECA™, a Next-Generation Fully Automated PCR Solution Featuring Customizable Pre-treatment Automation
- Seegene to showcase a conceptual video introducing CURECA™ at ESCMID Global 2025 — a full automation system expected to cover the entire PCR workforce, from sample pre-processing to result analysis.- Designed for 24-hour, seven-days-a-week, unattended, CURECA™ reflects the company's mission to set a new global standard and advance its vision of "a world free...
